copaydosingefficacyresourcesafety

THIS SITE IS INTENDED FOR US AUDIENCES ONLY

Connect with Us

Sign up to receive market access updates, resources to help your patients save, and useful information to help you along the treatment process.


Main Contact Information
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1789
+1 805-447-1000

Medical Information
Medical questions or adverse event reports can be directed to Amgen Inc. Medical Information at:

Phone
800-77-AMGEN (800-772-6436)

Email
medinfo@amgen.com

Web
www.amgenmedinfo.com

Fill in your information below

or

Indications & Important Safety Information

Please click here for Full Prescribing Information.

You are leaving the Otezla® (apremilast) website

Do you wish to leave this site?

Are You a Healthcare Professional?

.marketAccessModal .lineOne, .marketAccessModal .lineTwo { font-size: 44px; text-transform: none; margin-bottom: 10px; } .marketAccessModal .lineTwo { font-size: 42px; text-transform: none; } @media screen and (max-width: 450px) { .marketAccessModal .lineOne, .marketAccessModal .lineTwo { font-size: calc(15px + 7 * ((100vw - 325px) / 125)); } }
The FDA approves a new indication for Otezla® (apremilast) Learn more about this treatment option for your patients
EXPLORE